Steed Jordan, Gilliam Lisa K, Harris Robert A, Lernmark Ake, Hampe Christiane S
Robert H. Williams Laboratory, Department of Medicine, University of Washington, Health Sciences Building K-165, 1959 Pacific Avenue NE, Seattle, WA 98195-3771, USA.
J Immunol Methods. 2008 May 20;334(1-2):114-21. doi: 10.1016/j.jim.2008.02.006. Epub 2008 Mar 7.
The smaller isoform of glutamate decarboxylase (GAD65) is a major autoantigen in type 1 diabetes (TID). Its hydrophobic character requires detergent to keep the protein in solution, which complicates studies of antigen processing and presentation. In this study an attempt was made to replace detergent with human serum albumin (HSA) for in vitro antigen presentation. Different preparations of recombinant human GAD65 solubilized by HSA were incubated with Priess B cells (HLA DRB10401) and antigen presentation was tested with HLA DRB10401-restricted and epitope-specific T33.1 (GAD65 epitope 274-286) and T35 (GAD65 epitope 115-127) T-cell hybridomas. Specific epitope recognition by T33.1 (274-286) and T35 (115-127) cells varied between the different GAD65/HSA preparations, and a reverse pattern of antigen presentation was detected by the two hybridoma. The HSA-specific T-cell hybridoma 17.9 response to the different GAD65/HSA preparations followed the same pattern as that observed for the T33.1 cells. The content of immunoreactive GAD65 measured with four GAD65 antibodies indicated that the lowest GAD65 concentration resulted in the highest 274-286, but the lowest 115-127 presentation. This suggests that HSA-GAD65 interactions qualitatively affect the epitope specificity of GAD65 presentation. HSA may enhance the 274-286 epitope presentation, while suppressing the 115-127 epitope.
谷氨酸脱羧酶(GAD65)的较小异构体是1型糖尿病(TID)中的主要自身抗原。其疏水性需要去污剂来使蛋白质保持在溶液中,这使得对抗原加工和呈递的研究变得复杂。在本研究中,尝试用人血清白蛋白(HSA)替代去污剂用于体外抗原呈递。将不同制剂的经HSA溶解的重组人GAD65与普里斯B细胞(HLA DRB10401)孵育,并用HLA DRB10401限制性和表位特异性T33.1(GAD65表位274-286)和T35(GAD65表位115-127)T细胞杂交瘤测试抗原呈递。T33.1(274-286)和T35(115-127)细胞对不同GAD65/HSA制剂的特异性表位识别各不相同,并且两种杂交瘤检测到了相反的抗原呈递模式。HSA特异性T细胞杂交瘤17.9对不同GAD65/HSA制剂的反应与T33.1细胞观察到的模式相同。用四种GAD65抗体测量的免疫反应性GAD65含量表明,最低的GAD65浓度导致最高的274-286呈递,但115-127呈递最低。这表明HSA-GAD65相互作用在质量上影响GAD65呈递的表位特异性。HSA可能增强274-286表位呈递,同时抑制115-127表位。